Liothyronine (T3) and Tesamorelin Interaction

Monitor
Mechanism-based 50% confidence

Liothyronine (T3) and Tesamorelin have an interaction requiring monitoring for interaction with 50% confidence. Both Liothyronine (T3) and Tesamorelin promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

Liothyronine (T3)

Thyroid Hormone | Metabolic Optimization

Liothyronine enters target cells via monocarboxylate transporter 8 (MCT8) and other thyroid hormone transporters, then binds to nuclear thyroid hormone receptors (primarily TR-beta in metabolic tissues and TR-alpha in cardiac tissue). The T3-receptor complex forms heterodimers with retinoid X receptors (RXR) and binds to thyroid hormone response elements (TREs) on DNA, directly modulating gene transcription.

Half-life: ~1 day Typical dose: 25-75 mcg/day (replacement) metabolic, weight loss
thyroid receptor blood pressure raisingcardiotoxic
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low
Pituitary
low

Frequently Asked Questions

Can I take Liothyronine (T3) with Tesamorelin?

Yes, but with caution. Both Liothyronine (T3) and Tesamorelin promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. Regular monitoring is advised.

Is Liothyronine (T3) and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between Liothyronine (T3) and Tesamorelin?

Both Liothyronine (T3) and Tesamorelin promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.

How should I time Liothyronine (T3) and Tesamorelin?

Liothyronine (T3) has a half-life of ~1 day and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Liothyronine (T3) vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.